Proton Pump Inhibitors and Cyclin-Dependent Kinase 4/6 Inhibitors in Patients With Breast Cancer.
Kaori TakahashiRyuji UozumiToru MukoharaTetsu HayashidaMidori IwabeHirotoshi IiharaKanako Kusuhara-MamishinYuko KitagawaMasami TsuchiyaMika KitahoraAiko NagayamaShinkichi KosakaYoshimi Asano-NiwaTomoko SekiKoji OhnukiAkio SuzukiFumiko OnoManabu FutamuraHitoshi KawazoeTomonori NakamuraPublished in: The oncologist (2024)
The effectiveness of cyclin-dependent kinase 4/6 inhibitors is unlikely to be affected by concomitant PPI use. Future prospective pharmacokinetic studies are warranted.